Cleveland Clinic and IBM Co-Host Forum Showcasing Advances in Quantum Computing and AI in Healthcare
The third annual Cleveland Discovery and Innovation Forum, co-hosted by Cleveland Clinic and IBM, wa...
U.S. FDA Approves KEYTRUDA in Combination with WELIREG for Adjuvant Treatment of Renal Cell Carcinoma
The U.S. FDA has approved KEYTRUDA (pembrolizumab) and KEYTRUDA QLEX (pembrolizumab with berahyaluro...
South Korea's Rznomics Announces Interim Clinical Data for RZ-001 in Treating rGBM
Rznomics' RNA editing-based anticancer gene therapy, RZ-001 (Taspitimagene advec), has demonstrated ...
Ascendis Reports 182-Week Data for YORVIPATH in Hypoparathyroidism
Danish biopharmaceutical company Ascendis Pharma A/S (Nasdaq: ASND) announced 182-week data from the...
University College Dublin Discovers Cinquefoil Extract Can Inhibit Superbugs
A research team at University College Dublin has found that cinquefoil extract can effectively inhib...
Netherlands completes world's first in vivo CRISPR Phase III trial, reducing attacks by 87%
The research team has successfully completed the world's first Phase III trial of an in vivo CRISPR ...
U.S. Celldex Announces Positive Phase 1 Results for CDX-622
U.S. biopharmaceutical company Celldex (NASDAQ: CLDX) presented positive results from a Phase 1 stud...
US-based Parabilis Medicines Sets Drug Developer Fundraising Record with $770 Million IPO
Parabilis Medicines (Nasdaq: PBLS) became the largest IPO in drug developer history last week throug...
Legend Biotech's LB2501 Achieves 100% ORR in High-Dose Cohort in Phase 1 Trial
Legend Biotech Corporation presented Phase 1 clinical proof-of-concept data (Abstract #LB5006) for i...
China's Ascentage Pharma Announces 17 Clinical Updates at EHA2026
Ascentage Pharma Group (NASDAQ: AAPG; HKEX: 6855) announced 17 clinical updates on its core assets, ...